$TRS

TriMas (NASDAQ:TRS) Rating Lowered to "Strong Sell" at Zacks Research

Zacks Research downgraded TriMas (NASDAQ:TRS) from a "hold" to a "strong sell" rating. This follows a mixed performance from other analysts, with a consensus "Hold" rating and an average target price of $41.50. TriMas recently missed quarterly earnings estimates, reporting $0.40 EPS against $0.41 expected, and revenue of $155.49 million, below analyst estimates of $192.96 million.

Original reporting
MarketBeat · MarketBeat
Published Mar 7, 2026, 10:47 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 7, 2026, 11:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TriMas (NASDAQ:TRS) Rating Lowered to "Strong Sell" at Zacks Research — source image
Decision brief

The 30-second read

$TRSBearishHigh
01

Why it matters

The downgrade and earnings miss suggest increased downside risk, potentially leading to further price declines and sector-wide caution.

02

Market read

The news is highly relevant for traders holding or considering TRS, especially in the short term, due to the recent downgrade and earnings miss.

03

What to watch

Broader economic indicators and upcoming earnings reports could influence TRS's stock performance, potentially offsetting current negative signals.

Timing: Immediate to short-term (next 1-2 weeks)

Background

TriMas recently reported earnings below analyst estimates and was downgraded by Zacks Research, signaling deteriorating financial health.

Company-level read

Ticker impact

$TRSBearishMedium confidence
Context

High relevance due to recent downgrade and earnings miss.

Expected impact

Potential further decline of 5-10% in the near term, contingent on broader market conditions.

Evidence & confidence

The downgrade and earnings miss are significant negative signals; however, the overall industry and market sentiment are mixed, which introduces some uncertainty.

$TRSBearishMedium confidence
Context

High relevance as the primary subject of the news.

Expected impact

Possible decline of 5-10% over the next 1-2 weeks if current trends persist.

Evidence & confidence

The rating downgrade is a strong indicator of potential downside, but technical support levels and overall market conditions could influence actual price movement.

Market effects

Manufacturing and industrial sectors may experience slight negative sentiment due to company-specific issues.

Limited regional impact; primarily affects US-based manufacturing stocks.

Low; the news is specific to TriMas and its sector.

Counterpoint

Some analysts may view the downgrade as an overreaction, presenting a potential buying opportunity if fundamentals improve.

Key entities

  • TriMas Corporation

    A manufacturer of engineered products for various industrial markets.

  • Zacks Research

    An investment research firm providing stock ratings and analysis.

Related articles

$TRSMedAI 8/10

TriMas (TRS) Q2 2026 Earnings Call Transcript

TriMas (TRS) reported Q2 2026 net sales of $174.6M, up 1.6% YoY, with organic sales essentially flat. Adjusted operating profit rose 29% to $14.9M and adjusted EPS was $0.52. Management raised 2026 guidance to $1.60-$1.70 adjusted EPS and expects margin improvement, citing cost actions and interest income. Cash was $1.2B and net cash $846M after the Aerospace divestiture.

$TRSMedAI 8/10

TriMas (TRS) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 10:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations and Communications - Sherry Lauderback President and Chief Executive Officer - Thomas J. Snyder Chief Financial Officer - Paul A. Swart TAKEAWAYS Net Sales -- $174.6 million for the second quarter, representing a 1.6% increase year over year driven by favorable foreign currency translation.

$TRSMed

TriMas Corporation Q2 2026 Earnings Call Summary

TriMas held its Q2 2026 earnings call after divesting its Aerospace segment. Management said organic sales were flat as industrial and life sciences growth was offset by consumer pressure and macro uncertainty. Profit improved mainly from a $10.5M cost-reduction program. Full-year 2026 guidance: sales growth 3% to 6%, operating margin up 300+ bps, adjusted EPS $1.60-$1.70.

$TRSMed

TRIMAS CORP (TRS): Results of Operations and Financial Condition

TRIMAS CORP (TRS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 trs_06302026xexhibit991.htm EX-99.1 Document TRIMAS REPORTS SECOND QUARTER 2026 RESULTS Raises Low End and Midpoint of Full Year 2026 EPS Outlook • Second quarter operating profit increased to $10.9 million, while adjusted operating profit increased 29.1% to $14.9 milli

$BKRMed

Baker Hughes extends long-term service deal for Nigeria LNG Train 7

Baker Hughes said it won a 13-year lifecycle services deal with Nigeria LNG for turbomachinery at NLNG’s Train 7 expansion on Bonny Island. The scope covers heavy-duty gas turbines, centrifugal compressors, remote monitoring via Baker Hughes’ digital platform, and local support. Train 7 is expected to raise capacity from 22 to 30 MMtpa.